BUSINESS COMBINATION AND DECONSOLIDATION OF SUBSIDIARY (Details 1) - USD ($)	Jun. 30, 2019	Dec. 31, 2018
Net assets acquired:
Cash	$ 8,487,489
Note receivable from CURE	2,000,000
Property, plant and equipment	82,700
Patents and development technology	650,000
In-process research and development	14,460,000
Goodwill	9,178,477
Accounts payable	(353,856)
Payroll tax liabilities	(834,810)
Net assets acquired	33,670,000
Acquisition costs	399,942
Net assets acquired and acquisition costs incurred	$ 34,069,942